accountTop stories in today?s VentureWire Venture firms are uniting Astex Therapeutics Ltd. with publicly held SuperGen Inc. in an effort to create a company with the cash, pipeline and expertise needed to compete in the cancer-drug market. for $25 million...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to The Daily Start-Up: VCs Merge Two Biotechs
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account